© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
At the European AIDS Conference in Madrid, Dr. José Gatell talks with David Evans about the l
Want to have a baby? Dr. Valerie Stone checks in with David Evans about family planning for couples living with HIV.
At the 11th European AIDS Conference in Madrid, Dr. Jonathan Schapiro tells Peter Staley that an und
At the European AIDS Conference in Madrid, Dr. Jens Lundgren explains why HIV and its medications se
Over 2 million children are living with HIV/AIDS around the world. Dr. José Ramos talks with
Combination antiretroviral (ARV) treatment has significantly increased survival in people diagnosed with AIDS-related illnesses of the brain,...
An international study comparing Norvir (ritonavir)-boosted Prezista (darunavir) to Kaletra (lopinavir/ritonavir) in people starting treatment...
The higher a person’s CD4 count upon starting HIV treatment, the higher their CD4 count will be 60 months later, say British researchers at th...
An experimental lower-strength tablet version of Kaletra (lopinavir plus ritonavir) is expected to work well in HIV-positive children
Slow but steady progress is being made on several HIV prevention fronts, say researchers in a special symposium on HIV prevention at the 11th...
A decade after beginning triple-drug therapy with very low CD4 counts, a majority of patients in Belgian PICASSO cohort study remain alive
Crestor is superior to Pravachol in HIV-positive people on antiretroviral therapy who experience LDL cholesterol and triglyceride elevations
Dr. Jose Ramos talks with Peter Staley about the unique challenges facing HIV-positive children and their health care providers.
Dr. José Gatell talks with David Evans about the latest treatment news on Selzentry and the continued interest in Kaletra monotherapy.
The experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine is comparable to Sustiva in terms of reducing HIV levels a...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.